Emerging approaches for the treatment of hypertriglyceridemia

By Rizzo Manfredi   Perez-Martinez Pablo   Nikolic Dragana   Montalto Giuseppe   Lopez-Miranda Jose  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 14, 2013-10 ,pp. : 1869-1873

Informa Healthcare

Access to resources Recommend Favorite

Effects of icosapent ethyl (Eicosapentaenoic acid ethyl ester) on pharmacokinetic parameters of rosiglitazone in healthy subjects

By  

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 2, 2015-03 ,pp. : 143-148

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics of eicosapentaenoic acid in plasma and red blood cells after multiple oral dosing with icosapent ethyl in healthy subjects

By  

Clinical Pharmacology In Drug Development, Vol. 3, Iss. 2, 2014-03 ,pp. : 101-108

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hypertriglyceridemia: Associated Risks and Effect of Drug Treatment

By Jonkers I.J.A.M.  

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 6, 2001-06 ,pp. : 455-466

Adis International

Access to resources Recommend Favorite

Omega-3 fatty acid concentrates in the treatment of moderate hypertriglyceridemia

By Skulas-Ray Ann C   West Sheila G   Davidson Michael H   Kris-Etherton Penny M  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 7, 2008-05 ,pp. : 1237-1248

Informa Healthcare

Access to resources Recommend Favorite